The protocols used for brand versions of tirzepatide (Mounjaro, Zepbound) and semaglutide (Ozempic, Wegovy) are the averaged result of studies on large patient samples
Tirzepatide Tirzepatide has a dual mechanism of action
It not only helps patients achieve significant weight loss but also reduces risks for obesity-related conditions like Type 2 diabetes, heart disease, and hypertension
Another study found that semaglutide treatment significantly reduced liver fat levels in individuals living with non-alcoholic fatty liver disease, with over 70% of participants seeing benefit
Understanding How Semaglutide Works for Weight Loss and Diabetes Semaglutide, the active ingredient in FDA-approved medications like Wegovy, Ozempic, and Rybelsus, is a GLP-1 receptor agonist